184 related articles for article (PubMed ID: 33112375)
1. Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis.
Ma M; Ghosh S; Tavernari D; Katarkar A; Clocchiatti A; Mazzeo L; Samarkina A; Epiney J; Yu YR; Ho PC; Levesque MP; Özdemir BC; Ciriello G; Dummer R; Dotto GP
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33112375
[TBL] [Abstract][Full Text] [Related]
2. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
[TBL] [Abstract][Full Text] [Related]
4. Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma.
Song H; Sun N; Lin L; Wei S; Zeng K; Liu W; Wang C; Zhong X; Wang M; Wang S; Zhou B; Lv C; Liu W; Zhao Y
Cancer Sci; 2020 Oct; 111(10):3665-3678. PubMed ID: 32745318
[TBL] [Abstract][Full Text] [Related]
5. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
Zhao G; Yin Y; Zhao B
J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
[TBL] [Abstract][Full Text] [Related]
6. A natural molecule, urolithin A, downregulates androgen receptor activation and suppresses growth of prostate cancer.
Dahiya NR; Chandrasekaran B; Kolluru V; Ankem M; Damodaran C; Vadhanam MV
Mol Carcinog; 2018 Oct; 57(10):1332-1341. PubMed ID: 30069922
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
8. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.
Kawahara T; Ide H; Kashiwagi E; El-Shishtawy KA; Li Y; Reis LO; Zheng Y; Miyamoto H
Urol Oncol; 2016 Oct; 34(10):432.e15-23. PubMed ID: 27330033
[TBL] [Abstract][Full Text] [Related]
9. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL
Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975
[TBL] [Abstract][Full Text] [Related]
10. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo.
Sahranavardfard P; Firouzi J; Azimi M; Khosravani P; Heydari R; Emami Razavi A; Dorraj M; Keighobadi F; Ebrahimi M
J Cell Physiol; 2019 Nov; 234(11):20193-20205. PubMed ID: 31016725
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21.
Schmidt K; Carroll JS; Yee E; Thomas DD; Wert-Lamas L; Neier SC; Sheynkman G; Ritz J; Novina CD
Cell Rep; 2019 May; 27(8):2493-2507.e4. PubMed ID: 31116991
[TBL] [Abstract][Full Text] [Related]
14. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
[TBL] [Abstract][Full Text] [Related]
15. Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer.
Magani F; Bray ER; Martinez MJ; Zhao N; Copello VA; Heidman L; Peacock SO; Wiley DJ; D'Urso G; Burnstein KL
Mol Syst Biol; 2018 Aug; 14(8):e8202. PubMed ID: 30108134
[TBL] [Abstract][Full Text] [Related]
16. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
[TBL] [Abstract][Full Text] [Related]
17. ZIP9 Is a Druggable Determinant of Sex Differences in Melanoma.
Aguirre-Portolés C; Payne R; Trautz A; Foskett JK; Natale CA; Seykora JT; Ridky TW
Cancer Res; 2021 Dec; 81(23):5991-6003. PubMed ID: 34706862
[TBL] [Abstract][Full Text] [Related]
18. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
[TBL] [Abstract][Full Text] [Related]
19. The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.
Palomera-Sanchez Z; Watson GW; Wong CP; Beaver LM; Williams DE; Dashwood RH; Ho E
J Nutr Biochem; 2017 Sep; 47():113-119. PubMed ID: 28582660
[TBL] [Abstract][Full Text] [Related]
20. Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kwak C; Kim HH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]